We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Shortages and supply disruptions (17)
- Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1046 result(s) found, displaying 701 to 725
-
Market actionsSynthes Australia, in consultation with the TGA, is issuing a hazard alert for its BC Distractor Body, a component of the Craniomaxillofacial (CMF) Distraction System.
-
Market actionsRecall for product correction for Otto Bock A200, Skippi and Skippi Plus power wheelchairs
-
Market actions
-
Market actionsConsumers and health professionals are advised that Roche Diabetes Care, in consultation with the TGA, is undertaking a recall for product correction of its Accu-Chek Mobile glucose tests due to the potential for a commonly used antibiotic to interfere with blood glucose test results.
-
Safety alerts
-
Safety alertsConsumers and health professionals are advised that Medtronic, in consultation with the TGA, has issued a safety advisory to reinforce awareness of the need to confirm insulin dosage when using certain Medtronic Paradigm insulin pump models due to the risk of over-infusion.
-
Market actions
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alertsHospitals and other healthcare facilities are advised that, while Hospira Australia is making progress in implementing corrective actions to address the issues outlined below, new infusion pumps from the Plum A+ family still cannot be supplied in Australia.
-
Safety alertsThe TGA has tested three samples of a product labelled VigRX For Men capsules and found that two counterfeit samples contained sildenafil
-
Safety alertsThe TGA has tested four samples of a product labelled VigRX Plus tablets and found that two counterfeit samples contained tadalafil an undeclared substance
-
Market actionsZimmer, in consultation with the TGA, has issued a hazard alert regarding its Natural-Knee II System metal-backed patella.
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts